INNT
TOTAL INVALIDATION PROCESSED BY THE IB
12/25/2025
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Mark description
The mark consists of the term "DENK" where the vertical portion of the letter "D" extends above and below the letter, and there is a shaded circle inside the letter "d", all above the term "NUTRITION" in smaller letters. All on a shaded background.
Holders
Representatives
Scott Greenberg Locke Lord LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and chemical preparations for medical purposes for the treatment of diseases and conditions of alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genito-urinary system and sex hormones, antiinfectives for systemic use, musculo-skeletal system, nervous system and respiratory system; healthcare preparations, namely, food supplements and medical preparations for the treatment of disturbances with and support of digestive enzymes, for optimizing the supply of nutrients to mother and child, for the promotion of fertility, for the relief and elimination of lactose intolerance, for the development of teeth, bones and muscles growth, for care during pregnancy and breastfeeding, for supporting the memory, concentration and learning, for the care of the immune system, for the strengthening and maintenance of joints, cartilage, bones and muscles, for the magnesium supply of heart, nerves and muscles, for increasing the iron requirement, for increasing the sperm formation and for the folic acid care before and during pregnancy; dietetic preparations for medical purposes in the form of vitamins, mineral nutrients, trace elements, proteins and carbohydrates; food supplements for medical and non-medical purposes, namely, for the treatment of disturbances with and support of digestive enzymes, for optimizing the supply of nutrients to mother and child, for the promotion of fertility, for the relief and elimination of lactose intolerance, for the development of teeth, bones and muscles growth, for care during pregnancy and breastfeeding, for supporting the memory, concentration and learning, for the care of the immune system, for the strengthening and maintenance of joints, cartilage, bones and muscles, for the magnesium supply of heart, nerves and muscles, for increasing the iron requirement, for increasing the sperm formation and for the folic acid care before and during pregnancy
Class 35
Wholesale and retail store services featuring pharmaceutical and chemical preparations used in industry, science, agriculture, horticulture and forestry, especially for use in the foodstuff, food supplement, pharmaceutical and cosmetics industries
History of USPTO decisions and trademark events.
50 publications found
TOTAL INVALIDATION PROCESSED BY THE IB
12/25/2025
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/06/2025
INVALIDATION PROCESSED
12/06/2025
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/01/2025
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2025
CANCELLED SECTION 71
11/01/2024
NEW REPRESENTATIVE AT IB RECEIVED
06/10/2023
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/17/2023
FINAL DECISION TRANSACTION PROCESSED BY IB
08/31/2018
FINAL DISPOSITION NOTICE SENT TO IB
08/01/2018
FINAL DISPOSITION PROCESSED
08/01/2018
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/17/2018
REGISTERED-PRINCIPAL REGISTER
04/17/2018
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/30/2018
PUBLISHED FOR OPPOSITION
01/30/2018
NOTIFICATION PROCESSED BY IB
01/26/2018
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/10/2018
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/10/2018
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/10/2018
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2017
EXAMINER'S AMENDMENT ENTERED
12/20/2017
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/20/2017
EXAMINERS AMENDMENT E-MAILED
12/20/2017
EXAMINERS AMENDMENT -WRITTEN
12/20/2017
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/07/2017
NON-FINAL ACTION E-MAILED
11/07/2017
NON-FINAL ACTION WRITTEN
11/07/2017
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/03/2017
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/31/2017
APPROVED FOR PUB - PRINCIPAL REGISTER
10/12/2017
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2017
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2017
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2017
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/09/2017
NON-FINAL ACTION E-MAILED
08/09/2017
NON-FINAL ACTION WRITTEN
08/09/2017
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2017
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2017
ASSIGNED TO LIE
08/04/2017
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2017
NEW REPRESENTATIVE AT IB RECEIVED
04/13/2017
REFUSAL PROCESSED BY IB
01/27/2017
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/09/2017
REFUSAL PROCESSED BY MPU
01/09/2017
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/29/2016
NON-FINAL ACTION WRITTEN
12/28/2016
APPLICATION FILING RECEIPT MAILED
12/27/2016
ASSIGNED TO EXAMINER
12/23/2016
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/23/2016
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/22/2016
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.